Technology | Wearable Sensors | August 15, 2018

iBeat Heart Watch Now Shipping

Smartwatch device continuously monitors heart and blood flow biometrics, sends alerts if events detected or patient is not responding to prompts

iBeat Heart Watch Now Shipping

August 15, 2018 — iBeat recently announced the release and shipping of its iBeat Heart Watch. The heart and blood flow monitoring smartwatch will engage the user and can notify first responders for immediate medical aid if something appears to be wrong.

The iBeat Heart Watch looks and functions like an everyday watch, but inside has an array of sensors that measure heart rate, blood flow and other biometrics. These are analyzed in real-time, leveraging artificial intelligence (AI), to look for potentially worrisome changes, such as heart rate or blood flow slowing or stopping. If something appears to be off, the watch will engage the user and ask if everything is okay. If the user confirms the need for help or does not respond, the Heart Watch will automatically connect to the iBeat’s 24-hour dispatch team, who can send the appropriate help – emergency medical services, police, firefighters, friends or family. The watch also has an emergency button that can be pressed at any time to get users emergency or non-emergency aid.

According to the Centers for Disease Control and Prevention, every 43 seconds, someone in the U.S. suffers a cardiac emergency, and emergency response time can make the difference between life and death. Because these emergencies are often unwitnessed and can happen anywhere, the iBeat Heart Watch has the potential to reduce delays in emergency response times, which could save lives and possibly prevent a user from suffering brain damage or organ failure.

Features of the iBeat Heart Watch include:

  • Continuous heart rate and blood flow monitoring – Looks for changes in real-time and alerts the user when there might be a significant or potentially serious change;
  • Dispatch and emergency contact notifications – Immediately notifies iBeat’s 24-hour dispatch team, the user’s emergency contacts, and if needed, 911;
  • Emergency help button – Can be pressed at any time to get aid from friends, family, loved ones or emergency services;
  • No smartphone or wi-fi needed – Equipped with built-in cellular functionality that can send and receive calls for help; no phone, Wi-Fi, or Bluetooth pairing is required to set up or use the watch;
  • Built-in GPS – Alerts responders and designated contacts to the user’s exact location in an emergency;
  • User dashboard – Shows overall heart health, activity levels, location and any emergency-triggered incidents; and
  • Heart Hero Network – Access to the network that makes aid available to anyone, anywhere. With more than 1 million people trained in first aid and cardiopulmonary resuscitation (CPR), the network will be automatically alerted if a nearby iBeat Heart Watch user suffers a cardiac emergency.

While the iBeat Heart Watch is intended for use as an everyday watch or for those with a heart concern, it is also an ideal replacement and upgrade from the antiquated medical alert devices currently on the market, according to the company. Most medical alert systems are pendants that brand the user as sick or elderly and require the user to stay tethered to a base station – unable to be used outside the home. They do not have the ability to measure cardiac parameters or automatically call for help. In contrast, the iBeat Heart Watch is a stylish watch that gives users the freedom to go anywhere they want, whenever they want, and keeps them within reach of immediate emergency or non-emergency aid.

iBeat is pursuing U.S. Food and Drug Administration (FDA) approval for use of its Heart Watch as a medical device and recently partnered with two of the top leading life insurers and reinsurers, Transamerica and SCOR Global Life, to extend longevity.

For more information:

Related Content

Sedentary Lifestyle Cancels Out Heart Benefits of Normal Weight
News | Cardiac Diagnostics | January 09, 2019
January 9, 2019 — Researchers at the University of Florida have found that low levels of physical activity can put he
Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Overlay Init